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NLRP3 inflammasome A B S T R A C T
Polymicrobial sepsis (after cecal ligation and puncture, CLP) causes robust complement activation with release of C5a. Many adverse events develop thereafter and will be discussed in this review article. Activation of complement system results in generation of C5a which interacts with its receptors (C5aR1, C5aR2). This leads to a series of harmful events, some of which are connected to the cardiomyopathy of sepsis, resulting in defective action potentials in cardiomyocytes (CMs), activation of the NLRP3 inflammasome in CMs and the appearance of extracellular histones, likely arising from activated neutrophils which form neutrophil extracellular traps (NETs). These events are associated with activation of mitogen-activated protein kinases (MAPKs) in CMs. The ensuing release of histones results in defective action potentials in CMs and reduced levels of [Ca 2+ ]i-regulatory enzymes including sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA2) and Na + /Ca 2+ exchanger (NCX) as well as Na + /K + -ATPase in CMs. There is also evidence that CLP causes release of IL-1β via activation of the NLRP3 inflammasome in CMs of septic hearts or in CMs incubated in vitro with C5a. Many of these events occur after in vivo or in vitro contact of CMs with histones. Together, these data emphasize the role of complement (C5a) and C5a receptors (C5aR1, C5aR2), as well as extracellular histones in events that lead to cardiac dysfunction of sepsis (septic cardiomyopathy).
Introduction
Sepsis in United States kills more than 200,000 individuals per year and epidemiological studies show an increased incidence of deaths from sepsis and septic shock over the past two decades in US (Kumar et al., 2011; Martin et al., 2003) . Sepsis and septic shock are the most common cause of death among critically ill patients in intensive care units (ICUs) with estimated annual costs of care exceeding $17 billion (Angus et al., 2001; Dombrovskiy et al., 2007; Russell, 2006) . Despite nearly 100 clinical trials, there are no FDA-approved drugs for use in sepsis. We do not adequately understand the molecular events in sepsis in ways that have translational implications. Pathogenesis of sepsis is complex, with many immune and non-immune mediators involved. In 1904, William Osler noted, "It appears that patients are dying not from their infections but rather their reaction to them. Sepsis has traditionally been considered to be a result of an uncontrolled inflammatory response that results in organ dysfunction (Cho and Choi, 2014) . Four key areas in sepsis are endothelial dysfunction, coagulation abnormalities, alterations in cell function, and dysregulated cardiovascular responses (Evans, 2018) . It is also now realized that sepsis can cause progressive symptoms developing early as well as weeks, months or years after "recovery" from sepsis (Delano and Ward, 2016) . Aggressive early intervention for managing infection (bacterial cultures and antibiotics therapy), better managing resuscitation fluids and vasopressors, as well as improved mechanical ventilation that avoids barotrauma in patients with sepsis-related acute respiratory distress syndrome (ARDS) have been strongly recommended for improving survival of patients with sepsis (Howell and Davis, 2017; Rhodes et al., 2017) . When patients develop septic shock, there is often relentless progression to multi-organ failure and a lethal outcome (Gustot, 2011; Shapiro et al., 2009) .
Cardiac dysfunction due to sepsis, "septic cardiomyopathy", can happen in up to 80% of patients with septic shock (Beraud et al., 2014) . This condition may lead to mortality rates of 70% in these patients (Romero-Bermejo et al., 2011) , even though it is generally agreed that, for patients who survive sepsis, the cardiac defects are reversible, typically within 7-10 days after onset of sepsis (Romero-Bermejo et al., 2011) . Sepsis-related cardiac dysfunction does not confer long-term harm to the heart (Parker et al., 1984) . Cardiac-dysfunction includes reduced systemic vascular resistance, elevated cardiac output, reduced ventricular function and dilatation of ventricles (Parrillo et al., 1990) . Regarding pathogenesis of these events, some time ago a myocardial depressant substance was found in blood of septic patients that had in vitro suppressive effects on cardiomyocyte (CM) contractility and relaxation (Parrillo et al., 1985) . Subsequently, it was determined that a variety of proinflammatory cytokines (IL-1β, IL-6, TNF) had similar effects on CMs (Carlson et al., 2005; Kumar et al., 1996) . Our group found that rodent CMs exposed to C5a released cardiosuppressive cytokines including IL-1β, IL-6, and TNF (Atefi et al., 2011) . The multiplicity of cytokines with these activities has made it unlikely that in vivo neutralization or use of knock-out (K.O.) mice would effectively protect the heart during sepsis. Other factors that can similarly affect CMs include pathogen-associated molecular patterns (PAMPs) released from bacteria and damage-associated molecular patterns (DAMPs) released from injured tissues or apoptotic cells (Rudiger and Singer, 2013) . LPS is a prominent example of a PAMP, while histones (discussed in Section 3.4.) are examples of DAMPs released during sepsis.
Methods to assess heart function in sepsis
There are several non-invasive methods to assess heart function following sepsis including functional (Echocardiography; EchoDoppler), electrical (electrocardiograms; ECGs) measurements and biomarkers present in the plasma. These techniques are still commonly used in septic patients in the hospital to assess cardiac function and monitor the hemodynamic condition (Barnaby et al., 2018; Beraud et al., 2014; Guerin and Vieillard-Baron, 2016; Haileselassie et al., 2016; Ozdemir et al., 2016; Quinten et al., 2017; Shashikumar et al., 2017) .
Echo-Doppler studies
Echocardiographic assessment and Doppler imaging technology can detect numerous systolic and diastolic dysfunctions in different geometries of the heart (left and right) in patients with severe sepsis or septic shock. This technique can detect left ventricular (LV) and/or right ventricular (RV) systolic or diastolic dysfunction in patients with sepsis. The hemodynamic status in patients with septic shock can be assessed using echocardiographic views that may reveal LV and RV dysfunction (Guerin and Vieillard-Baron, 2016) . Echocardiographic studies have reported RV dysfunction in 55% of septic patients and combined RV and LV dysfunction in 53% of patients with sepsis/septic shock (Vallabhajosyula et al., 2017a) . There are also some sophisticated technologies for evaluation of cardiac systolic and diastolic functions in patients with sepsis; such as speckle-tracking echocardiography (STE). In a very recent review, STE was reported to be a useful predictor for mortality in patients with sepsis (Vallabhajosyula et al., 2018) .
Our recent observations of cardiac function (systolic and diastolic parameters) in septic mice by Echo-Doppler studies (using a Vevo 770 High-Resolution In Vivo Imaging System) have been quite informative regarding cardiac dysfunction in hearts of septic mice Kalbitz et al., 2016a) . Sepsis-induced heart dysfunction 8 hr after cecal ligation and puncture (CLP) has been documented in septic mice from our previous studies Kalbitz et al., 2016a, b; Kalbitz et al., 2015) as well as reports from other groups (Alhamdi et al., 2015; Boluyt et al., 2004; Hollenberg et al., 2001; Hoover et al., 2015; Zanotti-Cavazzoni et al., 2009) . We described in details of EchoDoppler measurements in septic mice in our previous publications Fattahi and Ward, 2017; Kalbitz et al., 2016a, b; Kalbitz et al., 2015) .
ECG studies
Septic patients may show different changes in their ECG including sinus bradycardia, prolonged PR interval, prolonged QT interval, and Osborn waves due to hypothermia following sepsis (Drake and Flowers, 1980; Tisdale et al., 2013; Varriale and Ramaprasad, 1995) . QRS attenuation and increases in QRS duration have also been seen in the ECG tracings in septic patients (Madias and Bazaz, 2003; Rich et al., 2002) . Sepsis can also induce myocardial depression and ST-elevation similar to what has been found in humans with myocardial infarction. (Hibbert et al., 2012; Y-Hassan et al., 2014) .
Evaluating patients with sepsis in the pediatric intensive care unit (PICU) using ECG has shown P waves (PWd), QT (QTd), T-peak to Tend (Tp-e) intervals and Tp-e/QT, Tp-e/QTc ratios that were significantly higher in septic patients compared to age-and sex-matched healthy children. The Tp-e/QT ratio was found to be a valuable tool in predicting mortality for the septic patients in the PICU (Ozdemir et al., 2016) . Some of the ECG changes in septic patients are seen in the septic mice including prolongation of the PR, prolongation of the QRS complex (Bustamante et al., 2002; Hoover et al., 2015) and prolongation of QTc intervals (Hoover et al., 2015) . Details of electrical method (ECG recordings) in mice have been described previously (Hoover et al., 2015) .
Biomarkers evaluations
Many biological markers (biomarkers) in plasma are elevated during the pathophysiological process of severe sepsis or septic shock. These markers may be used for diagnosis, prognosis and monitoring of clinical responses in septic patients. Only a few of the biomarkers currently are used routinely in the clinical setting of sepsis (due to the lack of sufficient sensitivity and specificity). Troponin-T (TnT) is one of the best known traditional cardiac biomarkers, being evaluated in plasma from patients with sepsis or septic shock at time of admission (Hamilton et al., 2012; Vallabhajosyula et al., 2017b) . TnT elevation has been shown to be associated with the higher risk of death in septic patients (Bessiere et al., 2013; Fromm, 2007; Gualandro et al., 2014; Mantzouris et al., 2013) . Different studies showed the levels of TnT to be associated with in-hospital and short-term (Vallabhajosyula et al., 2017b; Vasile et al., 2013) and even long-term mortality (Vallabhajosyula et al., 2017b) . However, it has been reported (using multivariate analysis data) that TnT levels per se do not predict mortality in patients with severe sepsis or septic shock. Echocardiographic variables (including LV diastolic dysfunction and RV systolic dysfunction; dilatation) have correlated with TnT levels in serum from septic patients (Landesberg et al., 2014) .
C-reactive protein (CRP) and procalcitonin (PCT) are used worldwide routinely, although neither of them is specific for sepsis (Giannakopoulos et al., 2017; Pierrakos and Vincent, 2010; Prucha et al., 2015) . It was reported that CRP and PCT are often elevated in other inflammatory conditions without sepsis (Henriquez-Camacho and Losa, 2014; Pierrakos and Vincent, 2010) . Some novel biomarkers include presepsin (sCD14-ST) (Endo et al., 2012; Masson et al., 2014; Novelli et al., 2013; Shozushima et al., 2011; Ulla et al., 2013; Yaegashi et al., 2005) , CD64 (Bhandari, 2014) , soluble urokinase plasminogen activator receptor (suPAR) (Eugen-Olsen et al., 2002; Koch et al., 2011) , proadrenomedullin (proADM) (Suberviola et al., 2012) and the soluble triggering receptor expressed on myeloid cells (sTREM-1) (Adib-Conquy et al., 2007; Ferat-Osorio et al., 2008) , Pentraxin 3 (PTX3) (Liu et al., 2014) , Creatine kinase (CK) (Hua et al., 2012; Oliveira et al., 2008; Zhang et al., 2012) , and CD73 (Bellingan et al., 2014; Hasko et al., 2011) were reported to be useful biomarkers for diagnosis and prognosis of sepsis.
Taken together, there is no reliable biomarker that is specific for sepsis. If novel reliable biomarkers with a high sensitivity and specificity are discovered in the future, they may be used in the clinical setting, probably as a useful tool to improve identification and subsequent treatment of septic patients.
Role of complement C5a in septic cardiomyopathy
It is known that sepsis causes robust complement activation, resulting in robust generation of C5a and it is also known that pathophysiology of polymicrobial sepsis in mice following CLP is C5a-dependent (Hoesel et al., 2007b; Niederbichler et al., 2006) . C5a is a powerful proinflammatory mediator generated at the midpoint of the complement system, interacting with its receptors (C5aR1 and C5aR2) after onset of sepsis. It is reported that interaction of C5a with its receptors is linked to many of adverse harmful consequences of sepsis (Czermak et al., 1999; Hoesel et al., 2007b; Huber-Lang et al., 2001a, b; Niederbichler et al., 2006; Riedemann et al., 2002 Riedemann et al., , 2003 Rittirsch et al., 2008) . C5a reacts with its receptors leading to the "cytokine storm", apoptosis of lymphoid cells, loss of innate immune functions of neutrophils (PMNs, polymorphonuclear leukocytes), cardiomyopathy, disseminated intravascular coagulation, and complications associated with development of organ dysfunction (Hotchkiss et al., 1999; HuberLang et al., 2001b; Ward, 2004 Ward, , 2010a Ward, 2010b) . These events, often lead to lethality. We have found that C5a causes dysfunction in both contractility and relaxation in CMs (Niederbichler et al., 2006) and that CMs exposed to C5a released proinflammatory cytokines such as IL-1β, IL-6, and TNF (Atefi et al., 2011) which may contribute to myocardial depression during sepsis (Fernandes and de Assuncao, 2012) . We have shown that C5a is associated with septic cardiomyopathy (Hoesel et al., 2007b; Kalbitz et al., 2016b Kalbitz et al., , 2015 Niederbichler et al., 2006) and that interception of C5a improves survival, reducing cardiac dysfunction in septic mice (Huber-Lang et al., 2001a; Kalbitz et al., 2016b; Niederbichler et al., 2006; Rittirsch et al., 2008) . Various types of antibodies and compounds such as peptides or nonpeptides have actively been developed. These substances act as inhibitors of complement components C5 and C5a and antagonists of the C5a receptor (Horiuchi and Tsukamoto, 2016) . Different reports demonstrated that infusion of a neutralizing antibody to C5a or C5a activity can be used as strategies to reduce cardiac dysfunction (Czermak et al., 1999; Flierl et al., 2009; Guo et al., 2000 Guo et al., , 2006 Hoesel et al., 2007a; HuberLang et al., 2001a, b; Laudes et al., 2002; Riedemann et al., 2004; Sprong et al., 2003) . We found that C5a receptors are expressed on normal humans CMs (Fattahi and Ward, 2017) and that C5a receptors are overexpressed on CMs following sepsis in mice (Atefi et al., 2011) . Our focus has been mainly on the early events developing after CLP, the time which the high levels of proinflammatory cytokines and extracellular histones are present in the plasma (Kalbitz et al., 2016a (Kalbitz et al., , 2015 . It is obvious that a better understanding of molecular events in sepsis is imperative. It is known that complement activation plays a deleterious role in the harmful effects of sepsis. Following is the list of the events occurring during sepsis which result in septic cardiomyopathy development. All of these events are dependent on C5a.
C5a effects on Ca 2+ homeostasis in cardiomyocytes
In earlier reports we found that C5a affects intracellular calcium ([Ca 2+ ]i) homeostasis and electrophysiological functions of CMs (Kalbitz et al., 2015; Kalbitz et al., 2016b ). Here we provide more details of how these events develop in CMs. Details of CMs isolation are described in our recent publications Kalbitz et al., 2016a, b; Kalbitz et al., 2015) . In CMs, phospholamban (PLB), located on membrane of sarcoplasmic reticulum (SR), plays a major role in [Ca 2+ ]i homeostasis and in regulation of cardiac function (Li et al., 2013; Luo et al., 1996; Simmerman and Jones, 1998) . Phosphorylation of PLB (phospho-PLB) occurs during development of septic cardiomyopathy. We hypothesized that phospho-PLB following C5a ligation with C5a receptors on CMs may underlie the defects in cellular calcium regulation in CMs. Western blotting using PLB and phospho-PLB specific antibodies revealed that C5a over one h induced progressive phosphorylation of PLB in a dose dependent manner (Fig. 1a) . Phospho-PLB enhances cardiac contractility by increasing SR Ca 2+ levels and [Ca 2+ ]i transients (Chu et al., 2000; Wegener et al., 1989 (Fig. 1b) . Furthermore, the amplitude of spontaneous Ca 2+ releases in the diastolic interval as observed in Fig. 1d -e increased with C5a dose (Fig. 1c) . In frames d-f of Fig. 1 , we determined the effects of C5a on CM responses to progressively elevated stimulation frequency, up to 5 Hz. At faster pacing frequencies, C5a caused sustained elevations of cytosolic Ca 2+ when compared to the absence of C5a (frames f and g) and reduced the transient amplitude. The mechanism to explain the frequency-dependent effects of C5aR1 activation is unclear but may be attributed to the prolongation of the Ca 2+ transient duration (Fig. 1h) in CMs exposed to C5a. The slower removal of Ca 2+ from the cytosol, especially at faster pacing rates, resulted in accumulation of cytosolic Ca 2+ which may cause diastolic dysfunction. Prolongation of the Ca 2+ transient duration is puzzling in the presence of increased phospho-PLB (Fig. 1a) and suggests that other mechanisms that affect [Ca 2+ ]i homeostasis may also be altered by C5a engagement of its receptors.
Sepsis-induced [Ca

2+
]i increases in CMs in a C5a-dependent manner
We have shown in our previous studies the importance of [Ca 2+ ]i flux during sepsis and found the presence of defective current densities for Ik1, L-type calcium channel, and Na + /Ca 2+ exchanger (NCX) in
CMs from septic mice (Kalbitz et al., 2016b) . We also showed effects of C5a on [Ca 2+ ]i homeostasis and electrophysiological functions in single CMs (Kalbitz et al., 2016b) . In this report, we used rat and mouse CMs to study the effect of C5a on [Ca 2+ ]i influx from CMs, either after incubation of rat CMs with recombinant rat C5a, rrC5a (in vitro studies) or mouse CMs after CLP to see effect of C5a receptor (in vivo studies).
The methodology was described in our previous report in which we measured [Ca 2+ ]i, using calcium indicator fluo-3 AM, in CMs after exposure to histones or after CLP (Kalbitz et al., 2015) . For the new studies we measured [Ca 2+ ]i in rat or mouse CMs by flow cytometry using calcium indicator fluo-3 AM labeled CMs. In Fig. 2 ]i measurements in mouse CMs after CLP as a function of time (frame d) and evidence that the absence of either C5a receptor prevented CLP-induced increases in mouse CMs (frame e). The increases in cytosolic [Ca 2+ ]i were associated with both systolic and diastolic cardiac dysfunction (Kalbitz et al., 2016b (Kalbitz et al., , 2015 . These data showing increased [Ca 2+ ]i by C5a are in line with the data for ROS in which we found ability of rrC5a to cause increased reactive oxygen species (ROS) in isolated rat CMs (Kalbitz et al., 2016a) . Use of wild type (Wt) mice and induction of sepsis resulted in increased ROS (Kalbitz et al., 2016a) in mouse CMs. We also found that ROS release by C5a also required C5a receptors (C5aR1 and C5aR2) (Kalbitz et al., 2016a) and that the response was significantly attenuated in the lack of either C5aR1 or C5aR2.
3.3. Reduced SERCA2, NCX and Na + /K + -ATPase in CMs during sepsis are C5a-dependent
One of the known events happening during septic cardiomyopathy is impaired calcium handling in CMs (Li et al., 2013) . We have recently shown that, when mice developed CLP-induced sepsis, there was a trio of homeostatic enzymes in heart that were impaired during sepsis (Fattahi and Ward, 2017; Kalbitz et al., 2016b ]i after CLP, indicating that these enzymes play an important homeostatic role in regulating cytosolic [Ca 2+ ]i in CMs (Zhang et al., 2004) . In CMs after systole, SERCA2 and NCX rapidly reduced [Ca 2+ ]i to presystolic levels.
During polymicrobial sepsis, it was shown that action potentials were faulty, together with the inability to regulate the increased [Ca 2+ ]i developing during diastole. We have shown that the enzymatic activities of these three enzymes that maintain homeostasis as well as their protein levels (as defined by ELISA, Western blot and mRNA data), were strikingly reduced after sepsis in heart (Fattahi and Ward, 2017; Kalbitz et al., 2016b) . Using immunofluorescent (IF) staining to detect the expression of plasma membrane Na + /K + -ATPase, we were able to detect the Na + /K + -ATPase of the plasma membrane. Fig. 3 shows expression of Na + /K + -ATPase of the plasma membrane on CMs from control mice (frame a) and in frozen heart tissue (frame b) from healthy mouse using IF staining. IF staining was performed as described in our previous report (Kalbitz et al., 2016b) . Anti-alpha 1 Sodium Potassium ATPase antibody (ab7671, Abcam) was used as primary antibody and goat antimouse IgG-AlexaFluor488 (Jackson ImmunoResearch) was considered as the secondary antibody for IF labeling. Our recent data with IF staining showed evidence of reduced levels of Na + /K + -ATPase of the CM in the septic mouse 8 h after CLP (Kalbitz et al., 2016b) . These reductions occurred as early as 8 h after sepsis, at a time that EchoDoppler measurements also showed defective cardiac function, all being the hallmark of the "cardiomyopathy of sepsis". Our data were in line with the earlier reports showing reduced levels of SERCA (He et al., 2007; Ren et al., 2002; Wu et al., 2004 Wu et al., , 2016 Wu et al., 2001; Zhu et al., 2005) and NCX (Hobai et al., 2015a, b) on CMs of septic mice. The cardiomyopathy was reversible, with the various parameters of responses returning to normal limits around 48-72 h after sepsis (Kalbitz et al., 2016b (Kalbitz et al., , 2015 . We have found that these events (reductions in homeostatic enzymes) were C5a receptor-dependent as these decreases during sepsis were significantly diminished in C5aR1 or C5aR2 K.O. mice (Kalbitz et al., 2016b) .
C5a causes NET formation and release of extracellular histones from PMNs
Robust activation of complement C5a during sepsis was associated with progressive impairment of the innate immune system in which C5a reacted with its receptors (C5aR1 and C5aR2) on PMNs (Ward, 2004 (Ward, , 2010a Ward and Gao, 2009 ). We described PMN dysfunction during sepsis, including defects in cytokine production and the respiratory burst, that were dependent on C5a and its receptors (Huber-Lang et al., 2002) . We showed C5a-C5a receptor signaling plays an essential role in neutrophil innate immunity during sepsis. Blockade of either the ligand or the receptor improved survival rates in experimental sepsis . As a recent discovery related to the effects of C5a on PMNs, C5a interacted with its receptors on phagocytes (mainly on PMNs) resulting in PMN activation to form neutrophil extracellular traps (NETs). In these events, extracellular histones were released along with products from PMN granules (Fattahi et al., 2015; Fuchs et al., 2010) . Histones acted as DAMPs when they were released into the extracellular space (Chen et al., 2014) . It has been shown that histones are released in response to inflammatory challenge, contributing to endothelial dysfunction, organ failure and death during sepsis (Kalbitz et al., 2015; Xu et al., 2009) . Extracellular histones appeared to function as major mediators responsible for harmful effects of sepsis (Alhamdi et al., 2015; Ekaney et al., 2014; Kalbitz et al., 2015; Wang et al., 2015; Xu et al., 2009 ). There was evidence of increased extracellular histones in plasma during sepsis which we found that an ELISA kit (from Roche Diagnostics, Hillsdale, MI USA) can detect all of 4 individual histones (H1, H2A, H2B, and H4). Histones have been postulated to be a major cause of death during sepsis (Alhamdi et al., 2015; Chaput and Zychlinsky, 2009; Ekaney et al., 2014; Kalbitz et al., 2015; Nakahara et al., 2013; Xu et al., 2009) . In "sterile sepsis" conditions such as ischemia/reperfusion (I/R), hemorrhagic shock or polytrauma, histones also appeared in the blood and may induce events in organs similar to those developing during infectious sepsis (Abrams et al., 2013; Allam et al., 2012) . Extracellular histones play important roles in pathogenesis of sepsis due to development of apoptosis in a variety of cells and proinflammatory effects, which can induce cell damage or death (Xu et al., 2015) . Histones are released into the extracellular space in three ways, either freely, as a DNA-bound nucleosome, or as a component of NETs. All three types have been detected in serum after trauma and sepsis (Alhamdi et al., 2015; Garcia-Gimenez et al., 2017; Huber-Lang et al., 2018; Kalbitz et al., 2015; van der Poll et al., 2017; Xu et al., 2009) . When in the extracellular space, histones act as DAMP proteins driving immune activation and cytotoxicity through interaction with toll-like receptors (TLRs), complement and cell membranes phospholipids (Marsman et al., 2016; Silk et al., 2017; Xu et al., 2011) . We have found the role of extracellular histones in polymicrobial sepsis to be very harmful for cells as there was evidence of damage to mouse hearts perfused with histones or isolated CMs incubated with histones, based on ECG tracings (Kalbitz et al., 2015) . A few studies (including our own) have shown that neutralizing antibodies to histones sharply reduced sepsis-induced organ dysfunction as well as greatly improving survival in septic mice (Kalbitz et al., 2015; Xu et al., 2009) . Histone appearance in septic plasma was complement C5a-and PMN-dependent and that both C5a receptors (C5aR1 and C5aR2) were required for histone presence in septic plasma (Kalbitz et al., 2015) . When we used neutralizing histone antibody (BWA3) in our septic mice, there was remarkably reduced heart dysfunction (as defined by Echo-Doppler parameters) 8 h after CLP-induce sepsis (Kalbitz et al., 2015) . We also showed increased levels of [Ca 2+ ]i in mouse CMs exposed to purified histones (from calf thymus), caused loss of homeostasis, especially in septic mice (Kalbitz et al., 2015) . A recent paper has described appearance of extracellular histones (including H2B and H3) in plasma from septic humans (Garcia-Gimenez et al., 2017; van der Poll et al., 2017) . Interestingly, the plasma levels of histones were remarkably similar to the levels we have found in mice with polymicrobial sepsis (Kalbitz et al., 2015) .
Sepsis causes NLRP3 inflammasome activation in CMs in a C5a-dependent manner
The inflammasome is a multiprotein complex that mediates the activation of proteins which are involved in the maturation and secretion of proinflammatory cytokines including IL-1β and IL-18 (Franchi et al., 2009; Martinon et al., 2002) and induction of 'pyroptosis' (cell death induced by bacterial products) (Fink and Cookson, 2005) . Caspase-1 ("IL-1 converting enzyme") promotes secretion of these proinflammatory cytokines (Franchi et al., 2009 ). NLRP3 (nucleotide-binding oligomerization domain-like receptor with pyrin domain protein 3), one of the NLR-subset inflammasomes, was introduced as an important mediator pathway of the innate immune system over the past decade (Martinon et al., 2002) . NLRP3 and the adaptor ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) are critical components of the inflammasome complex that links microbial and endogenous 'danger' signals to caspase-1 activation (Cerretti et al., 1992; Mariathasan et al., 2004; Martinon et al., 2002; Thornberry et al., 1992) . PAMPs can activate caspase-1 via Fig. 4 . Constitutive presence of components of the NLRP3 inflammasome and their upregulation in vitro and after CLP. In frame a. three normal mouse hearts were homogenized and lysed (TRIzol), and then subjected to RT-PCR mRNAs for GADPH, NLRP3, ASC, caspase 1 and IL-1β. As is evident, all components were detected (no reverse transcriptase, no RT). b. In vitro, mouse CMs were incubated with C5a or LPS (4 h at 37°C). As is evident, there was upregulation of NLRP3 in CMs incubated with either agonist. c. Mouse CMs in sham mice or in CLP mice (16 h), the latter showing a very large increase (> 50 fold) in mRNA for IL-1β. For each bar, n = 5. d. Frozen ventricles 12 h after CLP stained for IL-1β.
NLRP3 inflammasome Munoz-Planillo et al., 2009) . Several diseases have been associated with dysregulated activation of caspase-1 and secretion of IL-1β (Franchi et al., 2009) . There is also evidence of involvement of ASC in endotoxemia in mice (Mariathasan et al., 2004) . Several studies showed activation of NLRP3 inflammasome in different cardiac diseases or myocardial injuries (Bracey et al., 2013; Pomerantz et al., 2001 ), including our study on septic cardiomyopathy (Kalbitz et al., 2016a) . The studies have also shown the protective effects of blocking caspase-1 (Bracey et al., 2013; Hwang et al., 2001; Pomerantz et al., 2001) or IL-1β (Abbate et al., 2010) in myocardial ischemia. Using NLRP3 or Caspase-1 K.O. mice we showed remarkably decreased levels of extracellular histones in LPS-induced acute lung injury model (Grailer et al., 2014) . We also showed that extracellular histones could result in NLRP3 inflammasome activation (Grailer et al., 2014) . We have found evidence of the NLRP3 activation in heart during sepsis (Kalbitz et al., 2016a) . As shown in Fig. 4a , lysates from three different normal Wt hearts contained components of the inflammasome (NLRP3, ASC, caspase 1 and IL-1β). In frame b and c mRNA studies were performed on mouse CMs using RT-PCR with the NLRP3 and IL-1B primers. In frame b, control (con) CMs had mRNA for NLRP3 arbitrarily set at a value of 1, while addition of C5a or LPS caused 1.8 fold and 2.7 fold increases, respectively, in mRNA. Frame c shows that 16 h after CLP hearts had a great increase (approximately 50 fold) of IL-1β mRNA. Details of the RT-PCR technology and sequence of the primers for NLRP3 and IL-1β were described in our previous report (Kalbitz et al., 2016a) . In frame d, frozen sections from LVs 12 h after CLP stained for IL-1β showed upregulation of IL-1β consistent with the mRNA data in mouse heart after CLP (frame c). Control ventricle (not shown) did not show any staining for IL-1β. For IL-1β staining, rabbit anti-mouse antibody was used as primary (Abcam, Inc., Cambridge, MA, USA) and donkey anti-rabbit (AF-488) as secondary antibody (Jackson ImmunoResearch Laboratories). Details of the IF staining was described in our previous report (Kalbitz et al., 2016a) .The data in Figs. 4 suggest that CMs contain the NLRP3 inflammasome. We showed that the absence of NLRP3 (NLRP3 −/− mouse) has a protective effect against cardiac dysfunction as well as cytokine production during sepsis (Kalbitz et al., 2016a) . We also found reduced levels of histones release in plasma in NLRP3 and Caspase-1 K.O. mice compared to the Wt after CLP (Kalbitz et al., 2015) . Collectively, inflammasome can be a good therapeutic target for reducing the harmful effect of the sepsis leading to septic cardiomyopathy.
Sepsis induces MAPKs activation in CMs in a C5a-dependent manner
Mitogen-activated protein kinase (MAPK) family includes extracellular signal-regulated kinase (ERK), p38 and c-Jun NH2-terminal kinase (JNK). MAPK signaling is involved in a variety of cellular activities including proliferation, differentiation, survival, and death. Deviation from the strict control of MAPK signaling pathways has been implicated in the many human diseases (Kim and Choi, 2010) . Myocardial I/R was reported to activate the MAPKs pathways including ERK1/2, JNK1/2, p38; and other primary protein kinases like the cell survival kinase, Akt; and the sodium-hydrogen exchanger (NHE) kinase, p90RSK (Armstrong, 2004) . There are several reports of MAPK signaling in the myocardial I/R injury and attenuation of myocardial injury by modulating MAPKs activation (Gargiulo, 2014; Jeong et al., 2012; Kim et al., 2012; Suchal et al., 2016 Suchal et al., , 2017 Yu et al., 2015) . For instance, there is evidence that antioxidant and anti-inflammatory treatment is involved in MAPK signaling pathway (Suchal et al., 2016) . Using this protocol, there was a significant inhibition of active JNK and p38 proteins, associated with attenuation of septic cardiopathy or after I/R injury of the heart (Suchal et al., 2016) . However, there are limited data on the role of MAPKs in cardiac dysfunction during sepsis. Sepsis has been shown to induce upregulation of p38-(phosphorylation) in adult rat ventricular myocyte (Gupta et al., 2005) . Inhibition of TNF-α/ p38-MAPK/caspase-3 signaling pathway showed protection effect in myocardial injury in septic rats (Zhang et al., 2016) . In our recent report, using flow cytometry techniques, we showed the activation (phosphorylation) of the MAPK proteins including p38, JNK1/2 and ERK1/2, as well as Akt in the isolated CMs from septic rats at different time points after CLP. In addition, we could detect phosphorylation of MAPKs and Akt in rat CMs as a function of time after in vitro exposure to rrC5a . The septic mice lacking C5a receptors, C5aR1 or C5aR2 K.O., showed decreased levels of phosphorylated MAPKs (p38, JNK1/2 and ERK1/2) and phosphorylated Akt on the heart from the septic mice . It was of interest that selective inhibitor of p38 MAPK; water-soluble salt of SB 203580 could remarkably attenuate cardiac dysfunction in septic mice as measured by ECHO-Doppler and also by IF staining of the heart from the septic mice . These data suggest that cardiac dysfunction following sepsis appears to be linked to activation of MAPKs and Akt in heart which is C5a-or C5a receptor-dependent. Moreover, using selective p38 inhibitor can reduce these activation responses in the heart.
Conclusions
In this review, we have described in polymicrobial sepsis (following CLP) the appearance of extracellular histones in plasma in a C5a and in an NLRP3 inflammasome-dependent manner. Sepsis also caused MAPKs activation in CMs in a C5a-dependent manner. Collectively these events led to functional abnormalities associated with the "cardiomyopathy of sepsis". Fig. 5 summarizes our current data, linking C5a and C5a receptors and the role of extracellular histones to events that compromise the heart function during sepsis. In the proposed cascade, CLP caused robust complement activation with release of C5a, interacting with its receptors (C5aR1 and C5aR2), resulting in activation of the NLRP3 inflammasome and MAPKs in CMs and the appearance of extracellular histones, likely arising from activated neutrophils, which form NETs and resulting in the release of histones. These events induced reductions in key Ca 2+ regulatory proteins (SERCA2 and NCX) as well as Na + /K + -ATPase in CMs, leading to inability to clear cytosolic Ca 2+ after systole, defective action potentials, buildup of ROS and [Ca 2+ ]i and release of cytokines, ultimately leading to the "cardiomyopathy of sepsis". Our studies show evidence of involving complement C5a and its receptors, as well as extracellular histones in events that lead to cardiac dysfunction during sepsis (septic cardiomyopathy). As details of these pathways emerge, it might be possible to develop therapeutic strategies for blockade of the following targets: extracellular histones, the cardiac NLRP3 inflammasome, or MAPK proteins. Such interventions as well as blockade of C5a or its receptors would be expected to diminish the cardiomyopathy developing in sepsis. The neutralizing mAb to C5a appears to be safe for use in humans (Hammerschmidt et al., 1980; Stevens et al., 1986) . Since a significant number of septic patients develop cardiac failure which may be lethal, our data suggest that early interventions in sepsis such as low molecular weight inhibitors of C5a may prevent the sequence of events that leads to death because of impaired cardiac function. It should be noted that, with modern interventions that do not cause baro-trauma in lungs, the majority of septic patients survive and after recovery do not show evidence of cardiac dysfunction. We need to increase our knowledge in the field of sepsis to better understand molecular pathways responsible for cardiac dysfunction developing after sepsis. Such information would help us to target specific molecules or proteins to be used for potential treatment in patients with septic cardiomyopathy Institutes of Health (NIH) National Cancer Institute; the O'Brien Renal Center, the UM Medical School, the Endowment for the Basic Sciences (EBS), and the UM Department of Cell and Developmental Biology. This study was supported by NIH, General Medicine Grants GM29507 and GM61656 (to PAW). MJD would like to acknowledge the 2016 Research Scholarship from the Shock Society, and the 2017 Faculty Early Career Investigator Research Fellowship from the American Surgical Association Foundation which funded this research. LMF would like to acknowledge T32 HL007517, which supports her during her research fellowship. 
